GLP1 and GLP1/GIP are forms of medical weight loss medication.
What is the difference between GLP1 semaglutide and GLP1/ GIP tirzepatide?
Trizepatide is a dual glucose-dependent insulinotropic polypeptide–GLP-1 receptor agonist. This means this medication works on two different receptors, GIP and GLP-1. The GIP receptors are activated to improve insulin sensitivity, insulin secretion, satiety (feeling full), and fat burn (lipolysis). Simultaneously, the GLP-1 receptors are stimulated to decrease glucagon secretion, slow gastric emptying, and decrease appetite. Concurrent action on both GIP and GLP-1 produces weight loss, lowered cholesterol, and reduced cardiovascular risk for patients.
Q & A with Dr. Wes our Weight Loss Physician and Jerry Rodrguez RN-FACHE, MSN.
We love our customers, so feel free to visit during normal business hours.
2711 North Loop 1604 West, San Antonio, Texas 78258, United States
Mon | By Appointment | |
Tue | 09:00 am – 05:00 pm | |
Wed | 09:00 am – 05:00 pm | |
Thu | 09:00 am – 05:00 pm | |
Fri | 09:00 am – 05:00 pm | |
Sat | 09:00 am – 02:00 pm | |
Sun | Closed |
Copyright © 2018 Body Concepts Health Spa - All Rights Reserved.
Builder
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.